-
3 weeks ago | 
ophthalmologytimes.com | Sheryl Stevenson |Hattie Hayes
Author(s):,At the 2025 ASCRS meeting, Dr. Sarkisian presented 3-year data on the iDose TR from the FDA clinical trial. At the 2025 American Society of Cataract and Refractive Surgery (ASCRS) meeting in Los Angeles, California, the Eye Care Network spoke with dozens of presenters about the data they brought to the meeting. Steven R. Sarkisian Jr., MD, ABO, presented data from an FDA clinical trial of a travopost intracameral implant.
-
4 weeks ago | 
ophthalmologytimes.com | Eric D. Donnenfeld |Sheryl Stevenson |Hattie Hayes
Eric D. Donnenfeld, MD, presented clinical trial results evaluating the impact of lifitegrast on dry eye disease (DED) symptomatology and biomarkers—findings shared at the 2025 American Society of Cataract and Refractive Surgery Annual Meeting, held April 25–28 in Los Angeles, California. Lifitegrast, an immunomodulator that targets T cell pathways, stands out for its ability to modulate multiple aspects of the inflammatory cascade underlying DED.
-
4 weeks ago | 
ophthalmologytimes.com | Dilsher S. Dhoot |Mark R. Barakat |Martin Harp |Hattie Hayes
At ARVO 2025, in Salt Lake City, Utah, Dilsher Dhoot, MD, FASRS, and Mark Barakat, MD, talked about the PHOTON trial, 8 mg versus 2 mg during the matched dosing phase, and outcomes of shortened, maintained, or extended dosing intervalsEditor's note: The below transcript has been lightly edited for clarity. Hi, I'm here at ARVO 2025, and I'm presenting a poster for EYLEA HD and looking specifically at the PHOTON data. This is a post-hoc analysis.
-
1 month ago | 
ophthalmologytimes.com | Hattie Hayes |Emily Kaiser Maharjan
Robert Maloney, MD, cofounder of the Maloney-Shamie-Hura Vision Institute, announced he has retired from his surgical practice. Dr. Maloney recently completed a six-month sabbatical at Oxford University, during which he researched Harold Ridley, Stewart Duke-Elder, and the development of the intraocular lens.
-
1 month ago | 
ophthalmologytimes.com | Amar Shah |Sheryl Stevenson |Hattie Hayes
Author(s):,A significant proportion of cataract surgery patients exhibit hyperosmolar tear film both before and 1 month after surgery, underscoring the importance of preoperative screening and postoperative management to optimize visual outcomes. Amar P.
-
1 month ago | 
ophthalmologytimes.com | Hsin-Yu Yang |Martin Harp |Hattie Hayes
Author(s):,At ARVO 2025, in Salt Lake City, Utah, Hsin-Yu Yang talked about the 9-month results from her study on the effectiveness of DIMS spectral lenses in myopic retardation for the pre-myopic preschoolers in Taiwan. At ARVO 2025, in Salt Lake City, Utah, Hsin-Yu Yang talked about the 9-month results from her study on the effectiveness of DIMS spectral lenses in myopic retardation for the pre-myopic preschoolers in Taiwan.
-
1 month ago | 
ophthalmologytimes.com | Alex Choi |Martin Harp |Hattie Hayes
Author(s): , At ARVO 2025, in Salt Lake City, Utah, Alex Choi discussed his poster on APOE carrier genetic status and its relation to Alzheimer disease as well as changes of the retina that might reflect early signs leading to an earlier diagnosis of the disease At ARVO 2025, in Salt Lake City, Utah, Alex Choi discussed his poster on APOE carrier genetic status and its relation to Alzheimer disease as well as changes of the retina that might reflect early signs leading to an earlier diagnosis...
-
1 month ago | 
ophthalmologytimes.com | Anisha Kasi |Martin Harp |Hattie Hayes
Author(s):,At ARVO 2025, in Salt Lake City, Utah, Anisha Kasi talked about her presentation on how her team used the TriNetX database, a large database of over 150 million patients worldwide, to validate the connection between hidradenitis suppurativa and inflammatory eye conditions.
-
1 month ago | 
ophthalmologytimes.com | Xiaolin Wang |Martin Harp |Hattie Hayes
Author(s):,At ARVO 2025, in Salt Lake City, Utah, Xiaolin Wang, MS, talked about her presentation on in vivo imaging of retinal pigment epithelium metabolic function in AMD. At ARVO 2025, in Salt Lake City, Utah, Xiaolin Wang, MS, talked about her presentation on in vivo imaging of retinal pigment epithelium metabolic function in AMDEditor's note: The below transcript has been lightly edited for clarity. Hello. My name is Xaiolin Wang. I'm a senior research associate from Doheny Eye Institute.
-
1 month ago | 
ophthalmologytimes.com | Noemi Guemes-Villahoz |Martin Harp |Hattie Hayes
Author(s):,At ARVO 2025, in Salt Lake City, Utah, Noemi Guemes-Villahoz, MD, PhD, talked about 12-month results of vision-related quality of life in myopic children using combination treatment with atropine and DIMS (Defocus Incorporated Multiple Segments) spectacle lenses.
